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ABSTRACT 
Heterocyclic compounds have a role in most fields of sciences such as medicinal chemistry, biochemistry also another area of sciences. More than 
90% of new drugscontain heterocycles and the interface between chemistry and biology, at which so much new scientific insight, discovery and 
application is taking place is crossed by heterocyclic compounds. Compounds derived from heterocyclic rings in pharmacy, medicine, agriculture, 
plastic, polymer and other fields.Most active heterocycles that have shown considerable biological actions as antifungal, anti-inflammatory, 
antibacterial, anticonvulsant, antiallergic, herbicidal, anticancer activity. There is always a strong need for new and efficient processes in 
synthesizing of new Heterocycles.Alum have been used as a novel catalyst in the synthesis of Schiff’s bases. Synthesized Schiff’s bases are free 
from use of ICH class 1 and Class 2 solvents and also free from structural alerts genotoxic impurities. This review highlights on various aspects of 
heterocyclic compounds with its biological activity & regulatory assessment based on the ‘International Regulatory Standards’ . 
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INTRODUCTION 
Today there are a lot of heterocyclic compounds are known, 
day by day the number is increasing rapidly due to the 
enormous synthetic research and also their synthetic utility1. 
Heterocyclic compounds have a role in most fields of 
sciences such as medicinal chemistry, biochemistry also 
another area of sciences2. Thename heterocyclic comes from 
the Greek word “heteros” which means “different.” Generally, 
the Heterocyclic compounds are cyclic organic compounds 
that contain at least one hetero atom, the familiar hetero 
atoms are Nitrogen, Oxygen and Sulphur and other variety of 
atoms3.Heterocyclic compounds constitute the largest and 
most varied family of organic compounds. 
Heterocyclic chemistry is one of the most significant and 
important fundamental division of organic chemistry dealing 
with synthesis, properties, and applications of heterocycles4. 
History of Heterocyclic Chemistry: 
Two hundred years ago, the chemical science was an 
undivided field around 1900 a division into inorganic, 
organic and physical chemistry became necessary. An 
increase of factual material enforced a progressive 
segmentation into sub disciplines Heterocyclic compounds 
constitute the largest and most varied family of organic 
compounds5. 
The history of heterocyclic chemistry began in the 1800s, in 
step with the development of organic chemistry. Some 
noteworthy developments 1818. Brugnatelli isolates Alloxan 
from uric acid 1832. Dobereiner produces furfural (afuran) 
by treating starch with sulfuric acid1834: Runge obtains 
pyrrole ("fiery oil") by dry distillation of bones19066,7. 
Friedlander synthesizes indigo dye, allowing synthetic 
chemistry to displace a large agricultural industry1936: 
Treibsisolates chlorophyll derivatives from crude oil, 
explaining the biological origin of petroleum1951: Chargaff's 
rules aredescribed, highlighting the role of heterocyclic 
compounds (purines and pyrimidines) in the genetic code8. 
several notable development in  heterocycles are, In general, 
the physical and chemical properties of heterocyclic 
compounds are best understood by comparing them with 
ordinary organic compounds that do not contain 
heteroatoms9. 
Heterocyclic compounds have played an important role in 
medicinal chemistry. It helps into the development of 
various therapeutic agents. The chemistry of Heterocycles is 
an interesting branch in organic chemistry. Heterocyclic 
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compounds are widely distributed in nature. Almost all the 
compounds we know as drugs, vitamins, and many other 
natural products areheterocycles10. 
Classification of Heterocyclic Compounds: 
We classified heterocyclic compounds according to number 
of member and type of hetero atoms (N ,S , O, Se,…..) of such 
a replacement are numerous11. 
Aromaticity of heterocyclic compounds: 
Aromaticity is one of the most important concepts in 
chemistry and is of particular interest in understanding the 
structure and properties of heterocyclic compounds. 
Heterocyclic compounds play an important role in biological 
processes; hence, the scientists are trying to understand the 
chemistry of heterocyclic compounds in order to improve 
the quality of human life12,13. Aromaticity is of particular 
importance in understanding the structure and properties of 
heterocyclic compounds. In recent years, the quantitative 
assessment of Aromaticity has become possible using which 
the aromatic properties of heterocyclic compounds andtheir 
polycyclic fused derivatives can be determined14,15,16. 
More than 90% of new drugs contain heterocycles and the 
interface between chemistry and biology, at which so much 
new scientific insight, discovery and application is taking 
place is crossed by heterocyclic compounds17,18,19.  
Several new heterocyclic derivatives containing fused 
pyrazoloxazine moieties were synthesized via cycloaddition 
reactions of bi-nucleophilic dentates, including hydrazine 
hydrate and its derivatives as well as active methylene 
compounds and aniline derivatives, resulting in novel five-, 
six- and seven-membered heterocyclic compounds20,21,22. 
I. Medicinal significance of  Heterocyclic compounds: 
There is huge number of pharmacologically active 
heterocycliccompounds having application in many common 
diseases. There are huge number of pharmacologically active 
heterocyclic compounds having application in many common 
diseases as antimicrobial, herbicides, urinary antiseptics and 
anti-inflammatory agents. Some heterocycles exhibits 
antitumor, antibiotic, anti-inflammatory, antidepressant, 
antimalarial, anti-HIV, antimicrobial, antibacterial, 
antifungal, antiviral, antidiabetic activity23,24. 
II. Biological significance of Heterocyclic compounds: 
Few heterocyclic compounds containing the five-membered 
oxadiazole nucleus possessa diversity of useful biological 
effects.Moieties are important because of their 
versatilebiological actions. Following are categories of drugs 
are having heterocyclesnucleus &used for treatment of 
various diseases. Antihistaminic, Antioxidant, Antitubercular, 
Antidiabetic, Antiobesity as Antimicrobial, Anti 
inflammatory, Analgesic, Immunomodulatory agents, 
Antiepileptic, Antiviral, Antineoplastic, Antihypertensive, 
Antimalarial, Local Anesthetic, Antianxiety, Antidepressant. 
Antibiotics such as Penicillin’s, Cephalosporin25,26,27. 
III. Other versatile applications of Heterocyclic 
compounds: 
Heterocyclic compounds exhibit significant solvatochromic, 
photochromic, andbiochemi-luminescence properties. 
Theenormous applications of major heterocycles arein 
materials science as dyestuff, fluorescentsensor, brightening 
agents, information storage, plastics, and analytical reagents, 
supramolecular and especially in conjugated polymers. 
Furthermore they act as organic conductors, optical data 
carriers, organic light-emittingdiodes, semiconductors, 
molecular wires, photovoltaic cells, light harvestingsystems, 
liquid crystalline compounds andchemically controllable 
switches. 28,29,30. 
Regulatory affairs: 
Regulatory affairs (RA) professionals play critical roles in a 
pharmaceutical industry because it is concern about the 
healthcare product lifecycle, it provide strategic, tactical and 
operational direction and support for working within 
regulations to expedite the development and delivery of safe 
and effective healthcare products to individuals around the 
world.Drug development and commercialization is highly 
regulated the path to drug registration Marketing approval is 
paved with good intention but can be complicated Things 
change constantly31,32. 
Regulatory affairs in R&D: 
The regulatory affairs personnel work hand in hand with 
marketing and R&D to develop, innovative products that 
take advantage of new technological and regulatory 
developments to accelerate time to market. With new 
products expected to add significant revenues to the 
company’s bottom lines, small decreases in time to market 
equate to large material gains in revenue and profit. 
Employing adaptive clinical trial strategies, obtaining quick 
approval from regulatory authorities and avoiding pitfalls in 
processes can accelerate development of new products and 
help to reduce costly errors and time lags33,34 
Regulatory bodies in different countries: 
 Central Drugs Standard Control Organization 
 Therapeutic Goods Administration 
 Medicines and Health care products Regulatory Agency. 
 European Medicines Evaluation Agencies 
 European Directorate for Quality ofMedicines, 
 Medicines Control Council.  
 USA FDA Food and Drug Administration etc35,36. 
Example of Regulatory Assessment of Schiff’s bases using 
alum as a novel catalyst: 
To understand Regulatory Assessment of Hetrocyclic 
compounds here we taken example with our previously 
published work Synthesis, Characterization and Regulatory 
Assessment of Schiff’s bases using alum as a novel catalyst. 
Alum [KAI (SO4)2·12H2O] performs as a novel catalyst for 
the synthesis of Schiff’s bases from 6-methoxy naphthalene 
2-carbaldehyde with various substituted amines in good to 
excellent isolated yield (65–89%) using ethanol as a solvent 
at ambient temperature38. The synthetic scheme is provided 
below:
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Heterocyclic compounds have played an important role in 
medicinal chemistry. It helps into the development of 
various therapeutic agents. The chemistry of Heterocycles is 
an interesting branch in organic chemistry. We do not found 
synthetic research based on the regulatory science, hence to 
demonstrate safety, quality and efficacy of the synthesized 
compounds, regulatory science has been introduced as a 
back-bone of the synthesis. Our research demonstrated the 
following important aspects of the regulatory science: 
 Advancing product manufacturing and quality  
 Ensuring the safety and effectiveness of the compounds  
 Advancing to promote global health  
Our synthesized compounds are building blocks of the key 
starting materials of number of active pharmaceutical 
ingredients (API).  According to the International Conference 
on Harmonization of Technical Requirements for 
Registration of Pharmaceuticals for Human Use (ICH) 
guidance Q7 an “API Starting Material” is a raw material, 
intermediate, or an API that is used in the production of an 
API and that is incorporated as a significant structural 
fragment into the structure of the API. 
ICH is a joint initiative involving both regulators and 
research-based industry representatives of the European 
Union (EU), Japan and the United States (US) in scientific and 
technical discussions. The mission of ICH is to achieve 
greater harmonisation worldwide to ensure that safe, 
effective, and high quality medicines are developed.   
‘The Central Drugs Standard Control Organization (CDSCO)’ 
is the national regulatory body for Indian pharmaceuticals 
and medical devices, and serves parallel function to the  
‘European Medicines Agency (EMA)’ of the European Union,                            
‘the Pharmaceutical and Medical Devices Agency 
(PMDA)’ of Japan, ‘the Food and Drug Administration of 
the United States (USFDA)’ and ‘the Medicines and 
Healthcare Products Regulatory Agency (MHRA)’ of 
the United Kingdom37. 
Taking consideration of regulatory requirement (as provided 
in below flow chart 1) we have synthesized novel series of 
compounds containing biologically important pharma-
cophores and investigate their pharmacological activities.
  
Flow chart 1: 
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 Regulatory assessment on genotoxiciy of 
synthesized Schiff’s bases: 
In support of regulatory requirements and based on 
available various international regulatory standards/ 
guidelines derivatives of Schiff’s bases have been 
synthesized. 
These synthesized derivatives as described are meeting to 
the “international regulatory standards” as provided below: 
1. Use of Alum as a novel catalyst which is cheap, effective 
and non-hazardous. 
2. Use of class 3 solvent such as ethanol (aqueous ethanol), 
which is ecofriendly and very less toxic for human body. 
3. No use of toxic metals/catalyst such as Pb, As, Hg, Cd 
(Class 1 metals), Ni and Co (Class 2A metals) etc. 
4. Alkyl esters of P or S Acid, Aromatic Nitro groups, 
Aromatic Azo groups, Aromatic ring N-Oxide, Aromatic 
mono or dialkyalamino, Alkyl hydrazines, Alkyl 
aldehydes, N-methyl alcohol derivatives, 
Monohaloalkanes, large family of N and S mustards, N-
chloramines, Propiolactones and Propiosultones, 
Aromatic or Aliphatic Aziridinyls, Alkyl halides (both Ar 
and Aliph), Urethenes (Carbamates), Alkyl N 
Nitrosamines, Aromatic amines, N-Hydroxy derivatives 
and derived esters, Epoxides and Alkene derivatives are 
structural alert for genotoxicity and carcinogenicity. The 
whole synthesized derivatives having no structural alerts 
for these genotoxic impurities. Genotoxicity of the 
compounds can be evaluated using flow chart 2 as 
provided below: 
 
Flow Chart 2: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*QSAR: Quantitative structure–activity relationship model   **Ames test [7]: an impurity that has been demonstrated to be 
genotoxic in an appropriate genotoxicity test model, e.g. bacterial gene mutation.   ***TTC [7]: Threshold of toxicological concern 
 Regulatory assessment of Residual Solvents used during the optimization of process of Schiff’s bases: 
Table 1: 
Entry Solvent 
ICH Class 
of solvent 
Acceptance 
criteria (ppm) 
Defined by ICH guidance 
1 CHCl3 2 60 These solvents associated with less severe toxicity (Class 2) 
should be limited in order to protect patients from potential 
adverse effects. 
2 CH2Cl2 2 600 
3 THF 2 720 
4 DMF 2 880 
5 MeOH 2 3000 
6 ACN 2 410 
7 Dioxane 2 380 
8 DMSO 3 5000 Less toxic solvents (Class 3) should be used where practical. 
Solvents with low toxic potential to man; no health-based 
exposure limit is needed. Good yield in ethanol as compare to 
DMSO; hence ethanol is selected for the reaction. 
9 EtOH 3 5000 
Genotoxic Evaluation of the 
compounds 
Databases/literature 
Known mutagens 
carcinogens 
***Limit according to staged TTC 
*QSAR 
Compounds with 
structural alerts  
**Ames test  
Positive Negative 
Compounds without 
structural alerts  
 
Treated as non-genotoxic impurity 
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CONCLUSION 
Heterocyclic compounds play an important role in biological 
processes. Hence, the scientists are trying to understand the 
chemistry of heterocyclic in order to improve the quality of 
human life. Structural study of many of these compounds 
due to limited synthetic methods is difficult; however, using 
chemical calculations, assessments of sustainability and 
magnetic properties of many known or unknown 
heterocyclic compounds would be possible. 
There is always a strong need for new and efficient processes 
in synthesizing of new Heterocycles. Developing 
environmental friendly and effective technologies coupled 
with green chemistry is a major challenge facing the 
chemical community.  
Based on the information provided in this overview, we 
demonstrated that how industrial research to be connected 
to academic research so that academic research meets the 
more requirements of “international regulatory standards”. 
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